Indications for: ENSTILAR

Plaque psoriasis.

Adults and Children:

<12yrs: not established. ≥12yrs: apply to affected areas once daily for up to 4 weeks; max 60g every 4 days. Discontinue when control is achieved. Do not occlude.

ENSTILAR Warnings/Precautions:

Avoid use near eyes, on face, groin, or axillae, or if atrophy is present at treatment site. Discontinue if hypercalcemia or hypercalciuria develop; may resume once calcium metabolism has normalized. Discontinue or reduce dose or potency if HPA axis suppression, Cushing's syndrome, or hyperglycemia occurs. Increased risk of posterior subcapsular cataracts and glaucoma; monitor for visual symptoms. Flammable. Allergic contact dermatitis. Pregnancy. Nursing mothers.

ENSTILAR Classification:

Vit. D3 derivative + topical steroid.

ENSTILAR Interactions:

Systemic absorption potentiated by other corticosteroids.

Adverse Reactions:

Application site irritation and pruritus, folliculitis, skin hypopigmentation, hypercalcemia, urticaria, psoriasis exacerbation.

How Supplied:

Foam—60g, 2x60g